Swiss Reinsurance Company LTD
🤖
AI Overview
With $3.1M in lobbying spend across 32 quarterly filings, Swiss Reinsurance Company LTD is a significant lobbying presence. They deploy 15 individual lobbyists Their lobbying covers 10 issue areas. Active from 2018 to 2025.
$3.1M
Total Spend
8
Years Active
1
Firms Hired
15
Lobbyists Deployed
10
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $280K |
| 2019 | $360K |
| 2020 | $360K |
| 2021 | $360K |
| 2022 | $440K |
| 2023 | $440K |
| 2024 | $440K |
| 2025 | $440K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Agriculture, Health Issues, Taxation, Insurance, Roads/Highway and 5 more
- •Monitor potential efforts to reform the federal crop insurance program.
- •Oppose proposals to amend the Internal Revenue Code of 1986 to disallow the deduction for excess non-taxed reinsurance premiums with respect to United States risk paid to affiliates; monitor proposals
- •Monitor implementation of proposed regulations related to the creation of a Federal Insurance Office and reinsurance and systemic risk (P.L. 111-203, the Wall Street Reform and Consumer Protection Act
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Follow the Money
Tracking lobbying dollars through the financial system.
Foreign Governments Are Lobbying Congress
1,000+ foreign entities from 50+ countries lobby the US government.
The Crypto Lobbying Explosion
How crypto went from zero to massive lobbying presence.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.